Healthcare / Medical Care FacilitiesNYSE American
$3.55
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.4M · quality 44.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
32/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$29M
P/E
N/A
•EV/EBITDA
36.3x
↑ROE
13.1%
↑Gross Margin
76.6%
↑Debt/Equity
-0.62
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2010–2025 · 15 años de histórico normalizado
Revenue CAGR
+3.9%
FCF CAGR
+6.9%
FCF margin
16.6%
FCF / Net income
-2.16x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $31.6M · net income $-2.4M · FCF $5.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||
| Revenue | $31.6M | $31.6M | $32.0M | $31.3M | $30.3M | — | — | — | — | $25.4M | $23.1M | $21.1M | $20.1M | $19.0M | $18.0M | $17.9M | $17.8M |
| Net Income | $-2.4M | $-2.4M | $402095.00 | $-9.5M | $2.8M | $2.1M | $3.6M | $2.3M | $-854824.00 | $2.3M | $-1.3M | $8.1M | $553623.00 | $27436.00 | $-6.3M | $-2.1M | $3.5M |
| EBITDA | $1.1M | $1.1M | $5.7M | $-10.4M | $6.7M | $5.1M | $8.0M | $5.5M | $5.5M | $5.1M | $588267.00 | $3.0M | $2.2M | $1.9M | $-1.5M | $84492.00 | $3.6M |
| EPS | -0.30 | -0.30 | 0.05 | -1.15 | 0.33 | 0.25 | 0.45 | 0.27 | -0.11 | 0.30 | -0.16 | 0.83 | 0.05 | 0.00 | -0.56 | -0.18 | 0.29 |
| Gross Margin | 76.6% | 76.6% | 75.2% | 73.2% | 71.0% | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 15.3% | 15.3% | 11.8% | 11.1% | 14.7% | — | — | — | — | 19.7% | 1.9% | 13.9% | 9.8% | 9.0% | -9.5% | -1.5% | 18.8% |
| Net Margin | -7.7% | -7.7% | 1.3% | -30.4% | 9.1% | — | — | — | — | 9.1% | -5.7% | 38.4% | 2.8% | 0.1% | -35.1% | -11.7% | 19.5% |
| Balance Sheet | |||||||||||||||||
| Debt/Equity | -0.62 | -0.62 | -0.98 | -0.99 | -7.62 | 0.45 | -2.23 | -1.29 | -0.16 | -0.11 | -0.09 | -0.46 | -0.21 | -0.25 | -0.26 | -1.16 | -3.74 |
| Current Ratio | 0.62 | 0.62 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||
| Free Cash Flow | $5.2M | $5.2M | $2.4M | $1.3M | $-8.6M | $6.1M | $8.4M | $5.6M | $4.9M | $5.6M | — | — | — | $472196.00 | $227363.00 | $313407.00 | $1.9M |
| Returns | |||||||||||||||||
| ROE | 13.1% | 13.1% | -3.0% | 86.3% | -181.8% | 49.8% | -136.0% | -32.9% | 9.6% | -18.5% | 8.6% | -163.3% | -5.2% | -0.3% | 70.1% | 85.2% | -345.8% |
| Valuation | |||||||||||||||||
| P/E | — | — | 176.00 | — | 13.30 | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 36.35 | 36.35 | 14.87 | — | 7.09 | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||
| Revenue Growth | -1.3% | -1.3% | 2.0% | 3.3% | — | — | — | — | — | 9.8% | 9.7% | 4.8% | 6.0% | 5.7% | 0.3% | 0.9% | — |
| EPS Growth | -700.0% | -700.0% | 104.4% | -448.2% | — | -44.4% | 66.7% | 345.5% | -136.7% | 287.5% | -119.3% | 1560.0% | — | 100.0% | -211.1% | -162.1% | — |
| Dividend Yield | 17.2% | 17.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-11.4%
Start / end P/E
n/dx → n/dx
EPS bridge
0.05 → -0.30
Residual
-28.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.